These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29407964)

  • 1. Rational design of novel TLR4 ligands by in silico screening and their functional and structural characterization in vitro.
    Honegr J; Malinak D; Dolezal R; Soukup O; Benkova M; Hroch L; Benek O; Janockova J; Kuca K; Prymula R
    Eur J Med Chem; 2018 Feb; 146():38-46. PubMed ID: 29407964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational Design of a New Class of Toll-Like Receptor 4 (TLR4) Tryptamine Related Agonists by Means of the Structure- and Ligand-Based Virtual Screening for Vaccine Adjuvant Discovery.
    Honegr J; Dolezal R; Malinak D; Benkova M; Soukup O; Almeida JSFD; Franca TCC; Kuca K; Prymula R
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29300367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Class of Small Molecule Agonists with Preference for Human over Mouse TLR4 Activation.
    Marshall JD; Heeke DS; Rao E; Maynard SK; Hornigold D; McCrae C; Fraser N; Tovchigrechko A; Yu L; Williams N; King S; Cooper ME; Hajjar AM; Woo JC
    PLoS One; 2016; 11(10):e0164632. PubMed ID: 27736941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel toll-like receptor 4 (TLR4) antagonists identified by structure- and ligand-based virtual screening.
    Švajger U; Brus B; Turk S; Sova M; Hodnik V; Anderluh G; Gobec S
    Eur J Med Chem; 2013; 70():393-9. PubMed ID: 24177366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel small molecule TLR4 inhibitors as potent anti-inflammatory agents.
    Xu Y; Chen S; Cao Y; Zhou P; Chen Z; Cheng K
    Eur J Med Chem; 2018 Jun; 154():253-266. PubMed ID: 29807331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of small molecules targeting paclitaxel-induced MyD88 expression in triple-negative breast cancer cell lines.
    Poh Yen K; Stanslas J; Zhang T; Li H; Wang X; Kok Meng C; Kok Wai L
    Bioorg Med Chem; 2021 Nov; 49():116442. PubMed ID: 34600241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in silico approach towards the identification of novel inhibitors of the TLR-4 signaling pathway.
    Mahita J; Harini K; Rao Pichika M; Sowdhamini R
    J Biomol Struct Dyn; 2016 Jun; 34(6):1345-62. PubMed ID: 26264972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective virtual screening in a sparse data scenario: design of small-molecule TLR2 antagonists.
    Murgueitio MS; Henneke P; Glossmann H; Santos-Sierra S; Wolber G
    ChemMedChem; 2014 Apr; 9(4):813-22. PubMed ID: 24470159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational Approaches to Toll-Like Receptor 4 Modulation.
    Billod JM; Lacetera A; Guzmán-Caldentey J; Martín-Santamaría S
    Molecules; 2016 Jul; 21(8):. PubMed ID: 27483231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of new non-steroidal farnesoid X receptor modulators through 3D shape similarity search and structure-based virtual screening.
    Wang L; Si P; Sheng Y; Chen Y; Wan P; Shen X; Tang Y; Chen L; Li W
    Chem Biol Drug Des; 2015 Apr; 85(4):481-7. PubMed ID: 25228339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enrichment assessment of multiple virtual screening strategies for Toll-like receptor 8 agonists based on a maximal unbiased benchmarking data set.
    Pei F; Jin H; Zhou X; Xia J; Sun L; Liu Z; Zhang L
    Chem Biol Drug Des; 2015 Nov; 86(5):1226-41. PubMed ID: 26017460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances on Toll-like receptor 4 modulation: new therapeutic perspectives.
    Zaffaroni L; Peri F
    Future Med Chem; 2018 Feb; 10(4):461-476. PubMed ID: 29380635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
    Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
    J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential glutaminyl cyclase inhibitors from lead-like libraries by in silico and in vitro fragment-based screening.
    Szaszkó M; Hajdú I; Flachner B; Dobi K; Magyar C; Simon I; Lőrincz Z; Kapui Z; Pázmány T; Cseh S; Dormán G
    Mol Divers; 2017 Feb; 21(1):175-186. PubMed ID: 28070724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practices in Molecular Docking and Structure-Based Virtual Screening.
    Dos Santos RN; Ferreira LG; Andricopulo AD
    Methods Mol Biol; 2018; 1762():31-50. PubMed ID: 29594766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forging New Scaffolds from Old: Combining Scaffold Hopping and Hierarchical Virtual Screening for Identifying Novel Bcl-2 Inhibitors.
    Kanakaveti V; Rathinasamy S; Rayala SK; Gromiha M
    Curr Top Med Chem; 2019; 19(13):1162-1172. PubMed ID: 31210110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-silico screening of small molecule inhibitors against Lactate Dehydrogenase (LDH) of Cryptosporidium parvum.
    Dhal AK; Pani A; Mahapatra RK; Yun SI
    Comput Biol Chem; 2018 Dec; 77():44-51. PubMed ID: 30240985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and characterization of small-molecule TGR5 ligands with agonistic activity.
    Papadopoulos MGE; Perhal AF; Medel-Lacruz B; Ladurner A; Selent J; Dirsch VM; Kolb P
    Eur J Med Chem; 2024 Oct; 276():116616. PubMed ID: 38996653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to Prepare a Compound Collection Prior to Virtual Screening.
    Bologa CG; Ursu O; Oprea TI
    Methods Mol Biol; 2019; 1939():119-138. PubMed ID: 30848459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.